Abstract. Variant-and strain-specific immunity to malaria in Saimiri monkeys infected with homologous O and R variants of the Palo Alto strain (FUPSP) of Plasmodium falciparum or by various heterologous divergent strains were studied. Following homologous reinfections, the primary immune response in monkeys was effective only against the same variant type but not against the other variant, which differed only by antigens exposed at the surface of the infected red blood cell. In contrast, after two successive inoculations with a single variant type, a variant transcending immunity developed to both O and R parasite populations. The immunity against FUPSP in monkeys repeatedly infected with various combinations of heterologous strains, including Sal I, Tanzania, Camp, FUPCP, FCH4, FVO, and FUPCDC parasites was less effective, resulting at best in protecting the monkey against fulminating infection. However, in several cases, previous or concomitant heterologous infections modified the course of virulent infection by FUPSP parasites, indicating a significant degree of cross-protection between the strains. Therefore, in this model, while variant-and strain-specific antigens are important components of acquired immunity to malaria, the monkey immune response to infection transcends phenotypic antigenic variation and strain diversity.
Immunity to malaria in humans is poorly protective and only acquired slowly after several years of exposure to intense transmission. It is a nonsterile immunity and requires frequent boosting if it is to last. 1 Malaria parasites exhibit an extensive antigenic polymorphism as a result of two major factors, allelic diversity and antigenic variation. While antigenic diversity and host adaptation to it are likely to be important parameters to naturally acquired immunity to malaria, little is known about the relationship between antigenic diversity and the protective immune response against infection. 2 It has been suggested that the various allelic forms of genes interfere with and hinder the development of an efficient immune response such that protection is only achieved after exposure to a large number of antigenically distinct parasite strains. 3, 4 However, epidemiologic studies are not conclusive on this issue because of the complexity of natural parasite populations, host genetic diversity, and the possible presence of other immune evasion mechanisms such as antigenic variation. [5] [6] [7] [8] It is important to determine the effect of phenotypic variation and antigenic diversity on the development of immunity. This question should be easier to address in experimental models in which the infection is well characterized and controlled. By using different approaches (parasitologic, immunologic, and molecular), we studied the relative importance of conserved and polymorphic antigenic determinants in inducing an effective immunity against Plasmodium falciparum in a monkey model. In this communication, we report the pattern of infections of Saimiri monkeys successively injected with various combinations of two phenotypic variants of the Palo Alto strain of P. falciparum (FUPSP) or with a panel of heterologous strains, and their relationship to antibody response to surface exposed antigens. Our results demonstrated that while variant-and strain-specific antigens are important components of acquired immunity to malaria, there is a significant degree of overlapping between the various variants or divergent strains examined. Therefore, under our experimental conditions, the monkey immune response to P. falciparum infection transcends phenotypic antigenic variation and strain diversity. Furthermore, agglutination of Saimiri red blood cells infected with mature parasites by sera from protected and susceptible animals suggests that recognition of antigens exposed at the infected red blood cell surface is not an obligatory step for monkey protection.
MATERIALS AND METHODS

Monkeys.
The monkeys used were Saimiri sciureus sciureus from our breeding colony at the Institut Pasteur de Guyane (Cayenne, French Guiana). Animals were splenectomized approximately one month prior use, and received appropriate antibiotherapy to protect them from a possible Hemobartonella infection that was sometimes observed shortly after splenectomy.
Parasites. Numerous strains of P. falciparum are of potential use in the splenectomized Saimiri monkey, but the severity of the infection varies considerably between strains. Ten strains of P. falciparum were used in this study. The designation and geographic origin of parasite isolates, their propagation, as well as the Institutions from which they originated have been fully described elsewhere. [9] [10] [11] [12] The FUPSP monkey-adapted Palo Alto strain of P. falciparum, also designated FUPSP-O, FUP1, or PLF3 in other studies, typically induces lethal infections in Saimiri with high parasitemias (Ͼ 30%) that require appropriate drug therapy for control. 9 The conditions of selection of FUPSP-R parasites from the standard FUPSP-O line during passive transfer of immune antibodies have been detailed elsewhere. 13 These two lines are isogenic for more than 20 distinct genetic markers and equally virulent for splenectomized Saimiri. The O and R lines present distinct phenotypes at the infected red blood cell surface, and therefore are serologically distinguishable from each other: O parasites form rosettes, autoagglutinate, and have normal knobs on their surface, whereas R parasites do not show any of these characteristics. Since O and R parasites express surface-specific determinants, each variant is agglutinated by homologous convalescent antisera but not by heterologous convalescent antisera. They also produce different amounts of the histidine-rich protein (HRPI) and erythrocyte membrane protein 3 gene products, and show differential expression of a high molecular weight antigen reacting with antibodies against fusion protein 60.1, consistent with a switch in expression from one var gene to another. The FUPSP-O and -R lines are therefore undoubtedly two antigenic variants of the Palo Alto strain. 13, 14 The 12 Before and during the infection, blood samples were collected by femoral veinipuncture and antibodies were assayed either by indirect immunofluorescence using air-dried homologous parasites or by agglutination of infected cells. Parasitemia was monitored by examination of Giemsa-stained thin blood films.
Agglutination assay. The agglutination tests were performed with both O and R variants of the Palo Alto strain. 13 Agglutination of Saimiri red blood cells infected with late trophozoites and early schizonts was generally tested at a 1: 20 serum dilution in RPMI 1640 medium containing 20% decomplemented fetal calf serum (RPMI-FCS) and 20 g/ml of ethidium bromide. The assay was performed using fresh or cryopreserved FUPSP-infected monkey erythrocytes. Cryopreserved erythrocytes to be used in the assay were thawed and cultured for 15 hr in RPMI-FCS until the culture contained mostly late trophozoites or early schizonts. Five microliters of packed cells was added to 45 l of the serum dilution, and the mixture was gently rotated for 30 min at room temperature. Ten-microliter aliquots of the suspension were examined under UV illumination. 13, 15 Since agglutination may be prevented by an excess of antibodies, some of the sera that were negative were also tested at dilutions of 1:100 and 1:200. All remained negative at these higher dilutions.
Amplifications of MSA1 and MSA2. Amplifications were performed on genomic DNA in 50-l reaction volumes containing 5 M of each primer, 200 M of each dNTP, and 5 units of Taq polymerase (Promega, Charbonnieres, France or Amersham, Les Ulis, France). Samples were overlaid with oil and subjected to 35 rounds of denaturing at 95ЊC for 5 sec, annealing at 55ЊC for 90 sec, and synthesis at 74ЊC for 120 sec using a PHC3 thermocycler (Techne). The MSA1 (block 2) and MSA2 (repeats) fragments derived from polymorphic gene sequences were size-fractionated by agarose gel electrophoresis and compared for their size to reference fragments to be assigned to a strain. 12 This strategy allows unequivocal and semiquantitative detection of the parasite type contained in a blood sample. Amplification of a single fragment indicates the parasite population is homogenous, whereas visualization of a double band reveals that two populations are coamplified in the PCR.
RESULTS
Primary infections and challenges with homologous parasites: variant-specific immunity and protection. Sixteen naive monkeys received intravenous injections of 1-50 ϫ 10 6 FUPSP O or R parasites and developed severe infections rapidly reaching parasitemias greater than 10%, necessitating vigorous treatment between days 6 and 16 of the postinoculation period to prevent animal death (Table 1) .
Homologous reinoculations 60-360 days later were not invariably followed by protection or self-limited parasitemias, contrasting with the report by Hommel and others 16 for the PLF3 strain, the ancestor of the FUPSP strain, and by Roussilhon and others 17 for more recent passages of the FUPSP strain. Ten of the 16 monkeys displayed an infection pattern similar to that observed for the first inoculation (not protected). Monkey 1410, which was treated early during infection because of severe anemia, was similarly classified in such a category. Self-controlled infections with low-grade parasitemias below less than 6% were detected in five of the 16 monkeys (self-cured), whereas monkey 90055, which had a long-lasting infection but with a very low parasitemia that did not exceed 0.1%, was consequently considered fully protected.
In most homologous reinfections with the same variant (monkeys 90055, 90065, 1413, 90049, 1286, 90079, 89128, and 90071), the infection developed slowly and was followed by spontaneous termination of the parasitemia (five of eight). In contrast, only monkey i9202 from the second group (monkeys i9203, 1417, 1410, 1393, 1282, 1027, i9202, and i9201), challenged with variant parasites presenting a different surface phenotype, showed this pattern of slow-developing infection.
The number of homologous challenges required for partial or complete protection was further investigated. Different combinations of parasites were assayed. For instance, three monkeys that resisted the first challenge with the homologous variant in the first group of animals were reinfected with the other variant type (90055, 90949, and 1286) and three others, which were found susceptible (90065 and 89128) or resistant (90071) to reinfection, were reinoculated with the same variant. In the second group of monkeys, six inoculations were done with O parasites and the remainder with R parasites in such way to test the various combinations: (ORO, ORR, ROO, and ROR) at least once. Of the 16 monkeys reinfected, seven showed parasites in the period 7-14 days following inoculation and subsequently developed a low-grade parasitemia that did not exceed 1.3%, except for animal 90065, which had a parasitemia of 6.0% at day 17. 
Self-cured Protected Protected Protected Self-cured Protected Self-cured Protected * The variant type and the number of parasites injected, the maximum parasitemia during infection, and the day of maximum parasitemia in positive infections are indicated. The time (in days) between primary inoculations and homologous reinfections are indicated (in parentheses for the delay separating second and third inoculation). Self-cured means that the monkey recovered spontaneously from infection. It was protected if the parasitemia was less than 0.1%. Not protected refers to the development of a virulent infection generally with parasitemias greater than 10% that had to be treated to avoid animal death. The immunofluorescent antibody (IFA) titer is indicated for serum samples taken at the time of challenge. Inoc.
No antimalarial treatment was given to these animals and they all became negative between days 10 and 55 postinoculation. The protection conferred on the monkeys was long-lasting: in some cases it remained for more than one year (monkeys 1286 and 1282). Multiple heterologous infections and protection: strain-specific immunity and protection. Eight additional monkeys received 1-4 successive inoculations with heterologous strains of different genotypes (A to F) as indicated in Table 2 , and were then finally challenged with highly virulent FUPSP parasites of genotype A.
A similar pattern of infection was observed in monkeys 90016, 90026, and 90013; the FUPSP infection progressed to a high parasitemia that required drug treatment, as with nonimmune animals, whereas in four other monkeys, (89131, 90054, 90027, and 1805), reinfections with FUPSP parasites were considerably milder than those that developed in nonimmune animals. The infections progressed as lowgrade parasitemias (less than 3%), and were followed by a rapid decrease in parasite density to undetectable levels. Monkey 89103, which was injected with FUPCP parasites and subsequently with Indo I parasites (both of the B genotype), was resistant to reinfection. These data show that modification in susceptibility to infection occurs following heterologous infections but was less pronounced than that seen in homologous reinfections.
There was no obvious correlation between monkey resistance to challenges and the number, order, or genetic background of the parasites injected, and protection was acquired irrespective of the parasitic load. For instance, monkey 89131, which was injected only once with the Indo I strain of P. falciparum, resisted reinfection with FUPSP parasites, whereas monkeys 90026, 90013, and 90016, which received a larger number of inoculations, remained fully susceptible to heterologous challenge by FUPSP parasites. Indo I parasites of the B genotype conferred protection on monkey 89131 upon primary inoculation, although the Camp strain of a similar genotype did not elicited any protective immune response to FUPSP parasites in monkey 91013. Animals 90027 and 1805, which experienced only low parasitic loads during heterologous infections, resisted the challenge with FUPSP. In contrast, animals 90026 and 90013, with peak parasitemias of 3.2% and 6.1%, respectively, were not protected.
Parasite population dynamics and immunity in experimentally induced mixed infection. The possibility of inducing a protective immune response simultaneously against various strains of malaria parasites is of crucial importance with regard to vaccine development. However, under natural conditions of malaria transmission, the host is often infected by a complex mixture of genetically distinct parasite populations, and the presence of mixed populations may interfere with the immune response. We were concerned to learn if the monkey host would allow such mixed infections to be experimentally reproduced. Reported here are the results obtained from monkey 91035 given a primary injection with FVO and then superinfected 40 days later with FUPSP. Parasitemia values, obtained by microscopy, are presented in the upper part of Figure 1 and DNA amplifications, which provide the relative proportion of FVO and FUPSP parasites at a given time, are shown in the lower part of this figure.
TABLE 2
Characteristics of heterologous and terminal infections with FUPSP parasites* * Heterologous infections are numbered from one to five. The strain used, the day on which parasites were injected, the day (in parentheses), and the value of maximum parasitemia are also reported. The genetic characteristics of the various strains have been fully described elsewhere. 12 A single letter code indicates the genotype group of the strains (see the Materials and Methods). The IFA titer is given for samples collected from the various monkeys just before challenge by FUPSP parasites. Protected, self-cured, and not protected monkeys are as indicated in Table 1 . marg ϭ marginal parasitemia Ͻ0.01%. For definitions of other abbreviations, see Table 1 .
The FVO infection developed slowly, reaching a maximum parasitemia of 0.6% by day 32; it then decreased to 0.03% by day 40, at which time the animal was injected with FUPSP parasites. After reinoculation, the parasitemia increased to 1.2% and 4.2% at days 47 and 50, respectively, and was finally controlled by the animal. The PCR analysis carried out on blood samples collected at various times during patency indicated that both infections developed concomitantly for at least one week (from days 47 to 53) but FUPSP was consistently found to be predominant. Blood samples collected after day 60 postinoculation remained negative by PCR. The animal was challenged one year later with a mixture of Sal I and FVO parasites and developed a marginal infection composed mostly of FVO parasites, as deduced by PCR analysis.
Agglutination of FUPSP-infected erythrocytes with monkey sera. As shown in Tables 1 and 2 , antibody titers determined by fluorescence assay were poorly indicative of monkey susceptibility to reinfection. Monkeys i19201 (Table  1) and 91013 (Table 2) , with antibody titers of 1:10,240 and 1:20,480, respectively, were susceptible, while monkeys 89103 (Table 1) and 1286 (Table 2) , each with an antibody titer of 1:640, resisted the challenge with FUPSP parasites. When available, the serum samples collected at the time of challenge with FUPSP from the various monkeys were therefore examined at a 1:20 dilution for their ability to react with the surface of O-or R-infected red blood cells in a classic antibody-mediated agglutination assay. Such antigens located on the surface of schizont-infected erythrocytes are believed to be important factors for protective antibodies. 13, 15, 18, 19 Agglutinations with sera obtained during homologous infections are shown in the left part of Table 3 . Each serum collected after the first parasite booster injection reacted positively with the surface of the homologous variant but not with the surface of the other variant expressing distinct epitopes at the red blood cell surface. A weak cross-reactivity for O parasites was detected in sample 1413, but was no longer observed at higher serum dilutions. In two of the 11 samples examined (90065 and i9202), no positive reaction 90016  89103  89131  90054  90027  1805  90026  91013   4  2  1  3  3  3  2 2
* Sera (1:20 dilutions) from monkeys injected successively with homologous (Table 1) or heterologous (Table 2 ) strains, and collected just prior to reinfection by FUPSP, were examined for their reactivity with the surface of O-or R-infected erythrocytes in an antibody-mediated agglutination assay. Fresh FUPSP-O infected erythrocytes were from two monkey donors with parasitemias of 14% and 36%, respectively, whereas FUPSP-R infected blood was used either directly (7% parasitemia) or after cryopreservation (23% parasitemia) as indicated in the Materials and Methods. The agglutination was scored on a semiquantitative scale: Ϫ ϭ negative reaction; ϩ ϭ weakly positive reaction (agglutinates Ͻ5 infected cells [IC]); ϩϩ ϭ positive reaction (agglutinates 5-10 IC); ϩϩϩ ϭ positive reaction (agglutinates Ͼ10 IC), with each value being the average reactivity from two distinct experiments. P ϭ protected; NP ϭ not protected; ND ϭ not done; SC ϭ self-cured.
was obtained even at a 1:200 dilution. These samples were collected 50 days after the primary infection. Agglutinating antibodies were detected in monkey 90071 for a six-month period after the infection had been cleared.
The second inoculation did not have much of an effect on the specificity of the agglutination reaction. A general increase in antibody reactivities was detected, although similar (monkeys 9203 and i9201) and even lower (monkeys 90055 and 91071) reactivities were occasionally observed. An increase in agglutinating antibody titers was detected mostly in samples from animals reinfected with the heterologous variant, consistent with a typical secondary immune response against surface epitopes shared by the two variants.
Similarly, a semiquantitative agglutination analysis was performed on serum samples collected from the monkeys injected successively with the various heterologous strains of distinct genotypes. Three of eight sera collected just before challenge with FUPSP failed to react with the surface of any variant (monkeys 90016, 90027, and 90026), but sera from five other animals agglutinated slightly to strongly with at least one of the two O or R heterologous variants. Again, there was no simple correlation between the pattern of agglutination and resistance to reinfection. For instance, O but not R parasites were specifically agglutinated by sera from monkeys 89103 and 1805, yet these monkeys resisted reinfection with R parasites. Similarly, monkey 90027 was resistant to FUPSP infection although no agglutinating antibodies were detected in the serum.
DISCUSSION
Antigenic variation and antigenic diversity between strains are believed to play a key role in the development of immunity to malaria. We studied in a Saimiri model the effects of prior infection on subsequent infection with homologous or heterologous parasites with regards to parasitemia and immune response of the host. Care was taken not to inject the monkeys with large numbers of parasites and to provide enough time between each reinoculation so not to expose the animals to an excessive parasitic load. By reducing the time between successive inoculations to 1-5 days or by increasing the size of the inoculum (Ͼ 10 9 parasites) it was possible to override the immunity of resistant monkeys. Blood-induced infections were mostly well-tolerated by the monkeys, and even long-lasting parasitemias or high parasite densities did not induce either weight loss or clinical symptoms of severe disease such as lethargy, dyspnea, or neurologic problems. Thus, data collected from the Saimiri model are relevant to anti-infection immunity rather than to antidisease immunity. 20 We showed that homologous infections induced an efficient immunity usually established after a single exposure to parasites, or after two infections for parasites with different expression of antigens exposed at the red blood cell surface. The reduction of resistance resulting from an infection with any of the variant populations against that produced by the other variant type, which differed only for the surface-exposed antigens, indicated that the primary immune response was largely variant-specific. This response conferred protection to animals challenged with the homologous variant, but most animals remained fully susceptible to reinfection by the heterologous variant. In contrast, no severe infection was produced in these animals following the second challenge, indicating that the secondary immune response had transcended antigenic diversity at the red blood cell surface. Therefore, as few as two successive infections with homologous parasites, independently of the combination of variants used, are sufficient to overcome the diversity generated by phenotypic antigenic variation at the infected red blood cell surface, and to achieve complete and durable protection of the monkey.
Such challenges with homologous P. falciparum strains have been reported to be easier to control than those with heterologous parasites, both in therapeutic infections in humans and in primate models. 17, 21 However, this is not an absolute rule. In this study, a protective immune response was produced in some monkeys irrespective of the homologous or heterologous character of the challenge. Of the nine monkeys injected with heterologous parasites, six were either partially or completely protected against FUPSP, indicating a significant degree of overlap between the strains. The variability of the results following heterologous infections is difficult to explain, but it suggests that immunity becomes effective simultaneously against several strains if the response reaches a certain threshold. 20 This is consistent with the observation that FUPCP and FVO parasites produced self-limited infections in the Saimiri host but elicited a strong immune response that was protective against FUPSP infection even though the former (genotype B) differ from the later (genotype A) for all genetic markers examined so far. 11, 12 In comparison with homologous challenges, immunity acquired in monkeys following heterologous infections was less effective against a challenge with FUSP parasites, resulting at best in long-lasting, self-cured infections. As a result, the average duration of parasitemia observed in semiimmune animals was significantly longer than that in nonimmune monkeys. Interestingly, in endemic areas, such an increase in the average duration of parasitemia was also detected in older children who are similarly less susceptible to severe infection. 5, 20 The antibody-mediated agglutination assay showed that some sera from monkeys infected twice with the same variant cross-reacted with the heterologous variant presenting a distinct surface phenotype. Similarly, agglutinating antibodies to FUPSP-infected erythrocytes were detected in sera from monkeys injected with heterologous strains. This series of reactivities suggests that different strains may expose common antigenic determinants at the infected red blood cell surface. Importantly, the inability to agglutinate schizont-infected erythrocytes was not invariably associated with greater susceptibility to infection because some unreactive sera came from animals resistant to FUPSP infection. In Saimiri, the major effector mechanism used to eliminate parasites is phagocytosis of the infected red blood cells. 22, 23 Both processes imply cell surface recognition by antibodies, but the agglutination assay may not be able to identify antibodies promoting phagocytosis and vice versa. This raises the question of the targets and the immune effectors that are critical for protection. It is possible that in addition to a process of opsonization/phagocytosis, other alternative immune mechanisms not yet identified mediate parasite destruction in the Saimiri monkey. It is likely that strain and variant transcend-ing immunity correspond to distinct epitopes and distinct immune mechanisms. Acquisition of a protective immunity in Saimiri is likely to depend on both antigenic diversity as a result of allelic polymorphism and on phenotypic diversity as a result of antigenic variation. However, the characterization of the protective epitopes involved and the protective mechanisms evoked is still lacking.
In addition to data previously obtained from epidemiologic studies and from induced infections in humans, our results contribute to a better understanding of mechanisms of acquired immunity to malaria. Clearly, in the situation we have described, a protective immune response is mounted simultaneously against several variants or strains. Therefore, the possibility should be considered that the role of antigenic diversity, as a major mechanism for evading the host immune response, may have been overestimated in the recent years. Undoubtedly, antigenic polymorphism contributes to the slow acquisition of immunity in humans, but does it actually constitute a major hindrance to the development of a workable vaccine? This question can be now further studied by using the Saimiri model, in which complex infections are reproduced with characteristics similar to those of natural infections in humans. 5, 20, 21, 24 
